ÃÛÌÒ´«Ã½

University of Toledo Integrated Core Facilities (ICF)

Andrea L. Kalinoski, Ph.D.

Andrea Kalinoski, Ph.D. Professor
Director Integrated Core Facilities
Office: 419.383.4205
·¡³¾²¹¾±±ô:ÌýAndrea.Kalinoski@utoledo.edu

EDUCATION

B.A., Biology, University of Toledo, Toledo, Ohio 1994
Ph.D., Medical Sciences, Medical ÃÛÌÒ´«Ã½ of Ohio, Toledo, Ohio, 2003Ìý

POSTGRADUATE TRAINING

  • University of Toledo Health Science Campus, Department of Surgery, Toledo, Ohio 2003-2009Ìý

ACADEMIC APPOINTMENTS

  • 1994-1998: Medical ÃÛÌÒ´«Ã½ of Ohio, Department of Surgery, Research Associate, Toledo, OhioÌý
  • 2003-2009: Post-Doc Fellow, Department of Surgery, Toledo Ohio, Toledo OhioÌý
  • 2006-2013: Technical Director, Advanced Microscopy & Imaging Center, Toledo Ohio, Toledo OhioÌý
  • 2009-2014: Assistant Professor, University of Toledo, Department of Surgery, Toledo, OhioÌý
  • 2013-2024: Technical Director, UT Integrated Core Facilities (Advanced Microscopy & Imaging Center, Flow Cytometry and Histology), University of Toledo, ÃÛÌÒ´«Ã½ of Medicine and Life Sciences
  • 2015-2025: Associate Professor with Tenure, University of Toledo, Department of Surgery, Toledo, Ohio Ìý
  • 2024-Present: Director, UT Integrated Core Facilities (Advanced Microscopy & Imaging Center, Flow Cytometry, Histology and Transmission Electron Microscopy), University of Toledo, ÃÛÌÒ´«Ã½ of Medicine and Life Sciences
  • 2025-Present: Professor with Tenure, University of Toledo, Department of Surgery, Toledo, Ohio Ìý

RESEARCH FUNDING

  • SPARC OT2OD023859 Howard (PI) 10/15/2016-09/30/2019 NIH
    Role Kalinoski (CO-I) Anatomical-Functional Mapping of Enteric Neural Circuits
  • University Research Award and Fellowship Vestal (PI) 6/01/2018-05/31/2019Ìý
    Role Kalinoski (CO-I) GBP-1 in Glioblastoma
  • R01CA169500 Liu (PI) 05/01/2014-04/30/2018 NIH
    Role Kalinoski (CO-I) Trip12 AAA-ATPase overexpression in Chromosomal Instability and Breast Cancer

RESEARCH INTEREST

  1. Understanding the molecular signaling mechanisms within the vascular wall that results in the injury response and formation of neointimal hyperplasia.
  2. Understanding the signaling mechanisms within the vascular wall that result in fibroelastic changes and lead to arterial stiffness and/or decreased vascular tone.Ìý

INTEGRATED CORE FACILITIES

The University of Toledo Integrated Core Facilities acquire, maintain and support state-of-the-art equipment thatenables cutting-edge research to be performed by helping researchers economically and efficiently take advantage of innovative technology and collaborate with experts in the field.

PUBLICATIONS (SELECTED)

  1. Allison DC,ÌýNestor AL.ÌýÌý(1999)ÌýEvidence for a relatively random array of human chromosomes on the mitotic ring.ÌýÌýJ Cell Bio 145: 1-14.Ìý
  2. Assadnia S, Rapp JP,ÌýNestor AL, Cerilli GJ, Webb TH, Kligman M, Allison DC.ÌýÌý(1999) Strain differences in neointimal hyperplasia in the rat.ÌýCirc Res 84: 1252-1257.Ìý
  3. *Isaka T, *Nestor AL, Takada T, Allison DC.ÌýÌý(2003) Chromosomal variations within aneuploid cancer lines.ÌýÌýJ Histochem Cytochem 51(10): 343-1353.ÌýÌý(*equal authorship)
  4. Nestor AL, Cicila GT, Karol SE, Langenderfer KM, Hollopeter SL, Allison DC.ÌýÌý(2006) Linkage analysis of neointimal hyperplasia and vascular wall changes following balloon angioplasty.ÌýÌýPhysiol Genomics 25: 286-93.Ìý
  5. Nestor AL, Hollopeter SL, Matsui SI, Allison DC. (2007) A Model for Genetic Complementation Controlling the Chromosomal Abnormalities and Loss of Heterozygosity Formation in Cancer.ÌýÌýCytogenet Genome Res 116:235-247.Ìý
  6. Nestor Kalinoski AL, Ramdath RS, Langenderfer KM, Sikanderkhel S, DeRaedt S, Welch M, Park JL, Pringle T, Joe B, Cicila GT and Allison DC.ÌýÌý(2010) Neointimal Hyperplasia and Vasoreactivity are Controlled by Genetic Elements on Rat Chromosome 3. Hypertension 55(2):555-561.Ìý
  7. Stewart K, Olorunto W, Fink B, Zelenock, G, Allison DC,ÌýNestor Kalinoski AL.ÌýÌý(2010) Resuscitation with Ketones Improves Survival Over Lactated Ringers in a Rat Shock Model.ÌýÌýJACSÌý211(3):S52-3, 2010.
  8. Bazeley PS, NestorÌýKalinoski AL, Ways JA, Liu ST, Ramdath RS, Matsui SI and Allison, DC.ÌýÌý(2011) A Model for Random Genetic Damage Directing the Selection of Diploid or Aneuploid Tumors.ÌýÌýCell Proliferation 44: 212-223.ÌýÌýPMID: 21535262
  9. Wyse MM, Lei J,ÌýNestor-Kalinoski AL, and Eisenmann KM.ÌýÌý(2012)ÌýÌýDia-interacting protein (DIP) imposes migratory plasticity in mDia2-dependent breast cancer cells in three-dimensional matrices.ÌýÌýPLOS One 7(9): e45085.ÌýÌýPMID: 23024796.
  10. Gopalakrishnan K, Kumarasamy S, Abdual-Majeed S,ÌýKalinoski A, Morgan EE, Gohara AF, Nauli SM, Filipiak WE, Saunders TL and Joe B. (2012) Validation of a Blood Pressure Quantitative Trait Gene Using a Targeted Disruption Rat Model.ÌýÌýProc Natl Acad Sci U S A. 109(50):20555-9.ÌýÌýPMID: 23185005.
  11. Wagner DE, Eisenmann K ,ÌýNestor-Kalinoski AL, Bhaduri, SB. (2012) A Novel Microwave Assisted Solution Combustion Synthesis (MASCS) to Produce Europium Doped Calcium Phosphate Nanowhiskers for Multifunctional Bioimaging Applications.ÌýActa Biomaterialia.Ìý(9):8422-32.ÌýÌýPMID:ÌýÌý23764803.
  12. ,Ìý,Ìý,Ìý,Ìý,Ìý,Ìý,Ìý,Ìý. (2013)ÌýÌýDevelopment and Characterization of Nanostructured Mists with Potential for Actively Targeting Poorly Water-Soluble Compounds into the Lungs.ÌýÌýÌý10:2625-39.ÌýÌýPMID:ÌýÌý23722411.
  13. Weaver, DA,ÌýNestor-Kalinoski AL, Craig K, Gorris, M, Parikh T, Mabry H, Allison DC.ÌýÌý(2014) Correction of Sampling Errors Finds Increased mRNA Levels Possibly Compensating for Cancer Haplo-Insufficiency.ÌýÌýGenes Chromosomes CancerÌýÌý53(2):194-210ÌýÌýÌýPMID:ÌýÌý24327546.
  14. Pettee KM, Dvorak KM,ÌýNestor-Kalinoski ALand Kathryn M Eisenmann KM.ÌýÌý(2014)ÌýÌýAn mDia2/ROCK Signaling Axis Regulates Invasive Egress from Epithelial Ovarian Cancer Spheroids.ÌýÌýPLoS One.Ìý2014;Ìý9(2): e90371.ÌýÌýPMID:Ìý24587343.
  15. Morgan EE, Casabianca AB, Khouri S, and Nestor-Kalinoski, AL. (2014) In vivo Assessment of Arterial Stiffness in the Isoflurane Anesthetized Spontaneously Hypertensive Rat.ÌýÌýCardiovascular Ultrasound,Ìý12:37.ÌýPMID:ÌýÌý25227282
  16. Arden JD, Lavik KI, Rubinic KA, Chiaia N, Khuder SA, Howard MJ,ÌýNestor-KalinoskiAL, Alberts AS, Eisenmann KM.ÌýÌý(2015)ÌýÌýÌýMol Biol Cell. Nov;26(21):3704-18.ÌýÌýPMID:ÌýÌý26354425.
  17. McBeth L, Nwaneri AC, Grabnar M, Demeter J,ÌýNestor-Kalinoski A, Hinds TD Jr. (2016)ÌýÌýÌýOncotargetMay 10;7(19):27313-24.ÌýÌýdoi: 10.18632/oncotarget.8430.ÌýÌýPMID:ÌýÌý27036026.
  18. Wu X, Ren G, Gunning WT 3rd, Weaver DA,ÌýKalinoski AL, Khuder SA, Huntley JF.ÌýÌý(2016)ÌýÌýFmvB:ÌýA Francisella tularenisi Magnesium-Responsive Outer Membrane Protein that Plays a Role in Virulence.ÌýÌýPLoS OneÌýÌýAug11:11(8):e0160977.ÌýÌýdoi:10.1371/journal.pone.0160977. PMID:ÌýÌý27513341.
  19. Hinds TD, Jr., Burns KA,ÌýÌýHosick PA, McBeth,L,ÌýÌýNestor-Kalinoski, A, Drummond, HA,ÌýÌýAlAmodi, AA Hankins, MW, Vanden Heuvel, JP and Stec, DE.Ìý(2016)ÌýÌýBiliverdin reductase A attenuates hepatic steatosis by inhibition of glycogen synthase kinase (GSK) 3β phosphorylation of serine 73 of peroxisome proliferator-activated receptor (PPAR) α.ÌýÌýÌýJournal of Biological ChemistryÌýÌý291(48):25179-25191.ÌýÌýPMID:Ìý27738106
  20. Marino JS, Stechschulte L, Stec DE,ÌýNestor-Kalinoski A, Coleman S, Hinds Jr TD. (2016) Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of PPARα.ÌýÌýJournal of Biological Chemistry 291(50):25776-25788.ÌýÌýPMID:ÌýÌý27784782
  21. Nestor-Kalinoski, A.L.(2016) Second Harmonic Generation and Multiphoton Excited Fluorescence Microscopy as a Phenotypic Tool in an Animal Model. Microscopy and Microanalysis, 22(Suppl 3), 1060–1061. doi: 10.1017/S1431927616006140.ÌýÌý
  22. Hinds, TD Jr., Hosick PA, Hankins MW,ÌýNestor-Kalinoski AL, Stec DE.Ìý(2017) Mice with hyperbilirubinemia due to Gilbert’s syndrome polymorphism are resistant to hepatic steatosis by decreased serine 73 phosphorylation of PPARα.ÌýÌýAm J Physiol Endocrinol Metab ÌýApr 1;312(4):E244-E252.ÌýÌýdoi:10.1152/ajpendo.00396.2016. PMID:ÌýÌý28096081
  23. Wyse MM, Goicoechea S, Garcia-Mata R,ÌýNestor-Kalinoski ALand Eisenmann KM.ÌýÌý(2017)ÌýÌýmDia2 and CXCL12/CXCR4 chemokine signaling intersect to drive tumor cell amoeboid morphological transitions.ÌýÌýBiochemical and Biophysical Research Communications Mar 4;484(2):255-261.Ìýdoi: 10.1016/j.bbrc.2017.01.087. PMID:Ìý28115158
  24. Patel J, Ge L, Ahmed S, Ariyarantne M, Phuntumart V,ÌýKalinoski A, Morris PF (2017)ÌýÌýDual functioning of plant arginases provides a third route for putrescine synthesis.ÌýÌýPlant Science Vol 262: 62-73.ÌýÌýdoi.org/10.1016/j.plantsci.2017.05.011.
  25. Morran MP, Al-Dieri AG,ÌýNestorâ€�Kalinoski AL, Jordan RK, Gupta NK and McInerney MF.ÌýÌý(2018) Insulin receptor based lymphocyte trafficking in the progression of type 1 diabetes.ÌýÌýJournal of Biological Methods 5(1):e85. DOI:ÌýÌý10.14440/jbm.2018.209
  26. Dvorak KM, Pettee KM, Rubinic-Minotti K, Su R,ÌýNestor-Kalinoski A, Eisenmann KM. (2018)ÌýÌýÌýPLoS OneÌýMar 29;13(3):e0195278. doi:10.1371/journal.pone.0195278.ÌýÌýPMID:Ìý29596520
  27. Ren G, Zheng X, Bommarito M, Metzger S, Walia Y, Letson J, Schroering A, Kalinoski A, Weaver D, Figy C, Yeung K, Furuta S.ÌýSci Rep.Ìý2019 Apr 30;9(1):6688.Ìýdoi: 10.1038/s41598-019-43239-x.ÌýPubMed PMID: 31040372; PubMed Central PMCID: PMC6491486.
  28. Liu SH, Hong Y, Markowiak S, Sanchez R, Creeden J, Nemunaitis J, Kalinoski A, Willey J, Erhardt P, Lee J, van Dam M, Brunicardi FC.ÌýCancer Lett.Ìý2019 Aug 10;457:10-19.Ìýdoi: 10.1016/j.canlet.2019.04.036.ÌýEpub 2019 May 3.ÌýPubMed PMID: 31059751.
  29. Stec DE, Gordon DM, Nestor-Kalinoski AL, Donald MC, Mitchell ZL, Creeden JF, Hinds TD Jr.ÌýBiomolecules.Ìý2020 Mar 2;10(3).Ìýdoi: 10.3390/biom10030387.ÌýPubMed PMID: 32131495; PubMed Central PMCID: PMC7175174.
  30. Gordon DM, Neifer KL, Hamoud AA, Hawk CF, Nestor-Kalinoski AL, Miruzzi SA, Morran MP, Adeosun SO, Sarver JG, Erhardt PW, McCullumsmith RE, Stec DE, Hinds TD Jr.ÌýJ Biol Chem.Ìý2020 Jul 17;295(29):9804-9822.Ìýdoi: 10.1074/jbc.RA120.013700.ÌýEpub 2020 May 13.ÌýPubMed PMID: 32404366; PubMed Central PMCID: PMC7380202.
  31. Liu SH, Yu J, Creeden JF, Sutton JM, Markowiak S, Sanchez R, Nemunaitis J, Kalinoski A, Zhang JT, Damoiseaux R, Erhardt P, Brunicardi FC.ÌýCancer Lett.Ìý2020 Oct 28;491:97-107.Ìýdoi: 10.1016/j.canlet.2020.08.002.ÌýEpub 2020 Aug 21.ÌýPubMed PMID: 32829010; PubMed Central PMCID: PMC8766172.
  32. Pollard CA, Morran MP, Nestor-Kalinoski AL.ÌýPhysiol Genomics.Ìý2020 Nov 1;52(11):549-557.Ìýdoi: 10.1152/physiolgenomics.00089.2020.ÌýEpub 2020 Sep 29.ÌýReview.ÌýPubMed PMID: 32991251; PubMed Central PMCID: PMC7686876.
  33. Nandedkar-Kulkarni N, Esakov E, Gregg B, Atkinson MA, Rogers DG, Horner JD, Singer K, Lundy SK, Felton JL, Al-Huniti T, Kalinoski AN, Morran MP, Gupta NK, Bretz JD, Balaji S, Chen T, McInerney MF.ÌýJ Immunol.Ìý2021 Apr 1;206(7):1443-1453.Ìýdoi: 10.4049/jimmunol.1900357.ÌýEpub 2021 Mar 3.ÌýPubMed PMID: 33658296; PubMed Central PMCID: PMC8142694.
  34. Ren G, Zheng X, Sharma V, Letson J, Nestor-Kalinoski AL, Furuta S.ÌýCancers (Basel).Ìý2021 Jun 5;13(11).Ìýdoi: 10.3390/cancers13112815.ÌýPubMed PMID: 34198735; PubMed Central PMCID: PMC8201212.
  35. Margiotta JF, Smith-Edwards KM, Nestor-Kalinoski A, Davis BM, Albers KM, Howard MJ.ÌýFront Physiol.Ìý2021;12:652714.Ìýdoi: 10.3389/fphys.2021.652714.ÌýeCollection 2021.ÌýPubMed PMID: 34408655; PubMed Central PMCID: PMC8365335.
  36. Morgan EE, Morran MP, Horen NG, Weaver DA, Nestor-Kalinoski AL.ÌýPhysiol Genomics.Ìý2021 Dec 1;53(12):534-545.Ìýdoi: 10.1152/physiolgenomics.00038.2021.ÌýEpub 2021 Nov 10.ÌýPubMed PMID: 34755572; PubMed Central PMCID: PMC9275012.
  37. Nestor-Kalinoski A.L., Smith-Edwards K.M., Meerschaert K, Margiotta J.F., Rajwa B., Davis, B.M., Howard, M.J.Ìý (2021)Ìý Unique Neural Circuit Connectivity of Mouse Proximal, Middle and Distal Colon Defines Regional Colonic Motor Patterns. ÌýCell Mol Gastroenterol Hepatol. 2022;13(1):309-337.e3. doi: 10.1016/j.jcmgh.2021.08.016. Epub 2021 Sep 9. PMID: 34509687.
  38. Buckley KH, Nestor-Kalinoski AL, Pizza FX.ÌýFront Physiol.Ìý2022;13:845504.Ìýdoi: 10.3389/fphys.2022.845504.ÌýeCollection 2022.ÌýPubMed PMID: 35492593; PubMed Central PMCID: PMC9040890.
  39. Buckley KH, Nestor-Kalinoski AL, Pizza FX.ÌýInt J Mol Sci.Ìý2022 Jun 24;23(13).Ìýdoi: 10.3390/ijms23137028.ÌýPubMed PMID: 35806032; PubMed Central PMCID: PMC9267068.
  40. Beamer MA, Zamora C, Nestor-Kalinoski AL, Fernando V, Sharma V, Furuta S.ÌýSci Rep.Ìý2023 Jan 17;13(1):870.Ìýdoi: 10.1038/s41598-023-28233-8.ÌýPubMed PMID: 36650266; PubMed Central PMCID: PMC9845379.
  41. Sigdel I, Ofori-Kwafo A, Heizelman RJ 3rd, Nestor-Kalinoski A, Prabhakarpandian B, Tiwari AK, Tang Y.ÌýFront Bioeng Biotechnol.Ìý2023;11:1227119.Ìýdoi: 10.3389/fbioe.2023.1227119.ÌýeCollection 2023.ÌýPubMed PMID: 37840664; PubMed Central PMCID: PMC10569307.
  42. Collins SA, Stinson HE, Himes A, Nestor-Kalinoski A, Ninan I.ÌýSci Adv.Ìý2023 Nov 10;9(45):eadg4800.Ìýdoi: 10.1126/sciadv.adg4800.ÌýEpub 2023 Nov 10.ÌýPubMed PMID: 37948526; PubMed Central PMCID: PMC10637752.
  43. Creeden JF, Sevier J, Zhang JT, Lapitsky Y, Brunicardi FC, Jin G, Nemunaitis J, Liu JY, Kalinoski A, Rao D, Liu SH.ÌýJ Control Release.Ìý2024 Apr;368:413-429.Ìýdoi: 10.1016/j.jconrel.2024.02.037.ÌýEpub 2024 Mar 7.ÌýPubMed PMID: 38431093.
  44. Joshi K, Ahmed S, Ge L, Avestakh A, Oloyede B, Phuntumart V, Kalinoski A, Morris PF.ÌýPlant Sci.Ìý2024 Dec;349:112232.Ìýdoi: 10.1016/j.plantsci.2024.112232.ÌýEpub 2024 Aug 28.ÌýPubMed PMID: 39214468.
  45. Kumariya S, Grano de Oro A, Nestor-Kalinoski AL, Joe B, Osman I.ÌýBiochem Pharmacol.Ìý2024 Nov;229:116524.Ìýdoi: 10.1016/j.bcp.2024.116524.ÌýEpub 2024 Sep 7.ÌýPubMed PMID: 39251142; PubMed Central PMCID: PMC11929551.
  46. Kalb RC, Nyabuto GO, Morran MP, Maity S, Justinger JS, Nestor-Kalinoski AL, Vestal DJ.ÌýInt J Mol Sci.Ìý2024 Oct 19;25(20).Ìýdoi: 10.3390/ijms252011236.ÌýPubMed PMID: 39457021; PubMed Central PMCID: PMC11508455.
  47. Peterson JM, Leclair V, Oyebode OE, Herzallah DM, Nestor-Kalinoski AL, Morais J, Zahedi RP, Alamr M, Di Battista JA, Hudson M.ÌýInflamm Res.Ìý2025 Jan 31;74(1):31.Ìýdoi: 10.1007/s00011-025-01996-8.ÌýPubMed PMID: 39890639; PubMed Central PMCID: PMC11785624.
  48. Rafiqi SI, Aldasouqi A, Paparodis RD, Dewan S, Farooqi A, Faisal S, Nemat Y, Salim N, Qureshi S, Mahmood A, Tovar Y, Jun JY, Kalinoski AL, Mirmira RG, Jaume JC, Imam S.ÌýImmunotargets Ther.Ìý2025;14:205-226.Ìýdoi: 10.2147/ITT.S504555.ÌýeCollection 2025.ÌýPubMed PMID: 40099149; PubMed Central PMCID: PMC11912933.